Idoven AI-powered Cardiovascular Care

by Idoven  · Based in Spain → — AI-powered detection and precision medicine for cardiology
Cardiology Emergency Medicine Internal Medicine

Contact for pricing
Regulatory Status Disclosed

Overview

Idoven AI-powered Cardiovascular Care is a cloud-based, cardiology-as-a-service platform designed to assist healthcare professionals in identifying, triaging, and diagnosing cardiac arrhythmias and patterns at scale.

The platform is built for cardiologists, electrophysiologists, primary care physicians, and clinical researchers across various care settings, including hospitals, remote monitoring programs, and clinical trials. It serves medical device manufacturers (MedTech) and pharmaceutical companies (Life Sciences) by supporting digital diagnostics, patient risk stratification, and cardiac drug safety monitoring.

Integrating into clinical workflows, the software is device-neutral and ingests electrocardiogram (ECG) data of any duration (from 30 seconds to 30 days) in standard formats such as EDF, HL7, DICOM, JSON, XML, and PDF. It processes data from ambulatory ECGs (holters and patches), standard 12-lead resting ECGs, and insertable cardiac monitors (ICMs) via API or non-API tools to deliver analysis within minutes.

Notable capabilities of its core AI engine, Willem, include:

  • Automatic detection of 22 cardiac patterns and 4 key intervals (P interval, PR interval, QT interval, and QRS duration).
  • CE Mark certification as a Class IIa Medical Device under the EU Medical Device Regulation (MDR) 2017/745.
  • Compliance with ISO 13485, ISO 27001, and GDPR standards for data security and privacy.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered ECG interpretation and prediction
  • Detection of 22 cardiac patterns and 4 intervals
  • Device-neutral and interoperable with various ECG devices and EHR systems
  • Cloud-based platform for rapid analysis and results in minutes
  • Disease risk scores using ECG-based biomarkers
  • Continuous remote ECG monitoring from non-invasive devices
  • Reduction of false positive detections in ICMs by 98%
  • Integration into existing clinical and research workflows
  • Secure cloud infrastructure with ISO 27001, 27017, 27018, 27701, 13485, 37001, 42001 certifications and Spanish National Security Scheme
  • Ability to analyze ECGs of any duration (30 seconds to 30 days)

Use Cases

  • Rapid and accurate identification of arrhythmias and cardiac patterns for MedTech companies
  • Development of digital biomarkers for Life Sciences, including prediction, cardiotoxicity, and risk stratification
  • Preventative screening programs with continuous remote ECG monitoring and medical-grade reports
  • Streamlining and standardizing cardiovascular safety monitoring during clinical trials and post-market approval for pharmaceutical companies
  • Triage and diagnosis of patients at scale, reducing manual workload for physicians
  • Early detection of heart failure in primary care

What Physicians Need to Know

ECG/EKG Analysis Capability
Idoven's AI-powered platform, Willem, analyzes ECG data from various devices (1-lead wearables, patches, 12-lead hospital ECGs, Holters, and Insertable Cardiac Monitors) to detect 23 unique cardiac patterns with cardiologist-level accuracy. It can analyze 30-second ECGs in seconds and 24-hour Holters in under 5 minutes, significantly improving speed, consistency, and accuracy of interpretation.
Echocardiography AI Features
While Idoven primarily focuses on ECG analysis, AI in echocardiography is a developing field that enables patient-specific cardiovascular assessment for targeted therapy, cardiotoxicity risk prediction, and cardiomyopathy risk stratification. Idoven's core offering is ECG-based, but their platform's device neutrality and interoperability could potentially integrate with future echocardiography AI outputs.
Cardiac CT/MRI Analysis
Idoven's current offerings do not explicitly detail Cardiac CT/MRI analysis capabilities. Their primary focus is on leveraging AI for ECG interpretation and prediction.
Arrhythmia Detection Accuracy
Idoven's AI algorithm has demonstrated high accuracy in arrhythmia detection. It achieved 96.4% accuracy in detecting atrial fibrillation (AF) from single-lead ECGs. In collaboration with Abbott, Idoven's AI improved ICM accuracy by 95.4% for arrhythmia detection and reduced false positives by 98%. The platform can identify 86 electrical heart disturbances, covering 90% of common cardiac problems.
Heart Failure Risk Prediction
Idoven develops disease risk scores using ECG-based biomarkers to identify high-risk patients for various cardiovascular diseases. They have a model that identifies patients at increased risk of developing persistent atrial fibrillation within the next 6 months. Idoven is also collaborating on projects to detect heart failure, including an initiative with AstraZeneca and Fitbit to identify and monitor high-risk patients in minutes. The FAITHFUL Consortium, led by Idoven, aims to revolutionize heart failure detection in primary care, with a goal to reduce hospital admissions by 40%.
Coronary Artery Assessment
Idoven's ASSIST Consortium is developing the world's first AI-based solution for early diagnosis and accurate triage of acute myocardial infarction (heart attack), which involves the obstruction of coronary arteries. This project aims to improve accuracy and reduce diagnosis time by up to 67%.
Cardiac Monitoring Integration
Idoven's solution is device-neutral and interoperable, capable of analyzing data from various monitoring devices including wearables, patches, Holters, and implantable cardiac monitors (ICMs). They offer continuous remote ECG monitoring from non-invasive devices and integrate seamlessly into clinical workflows via API and non-API tools.
AHA/ACC Guideline Alignment
Idoven's platform, Willem, is a CE-marked medical device software, compliant with EU MDR regulations for the assessment of arrhythmias. While specific alignment with AHA/ACC guidelines is not explicitly stated, their focus on medical-grade reports and peer-reviewed publications suggests adherence to high clinical standards.
Real-Time Alert Capability
Idoven's platform aims to provide results in 'almost real-time,' with 30-second ECGs analyzed in seconds. Clinicians can monitor patients remotely and receive alerts for troublesome trends in real-time, enabling intervention before hospitalization.
Physician Tip

Idoven's AI can significantly reduce the manual burden of ECG interpretation, allowing for faster and more accurate diagnoses, especially for high volumes of data from continuous monitoring devices. Leverage its predictive capabilities for early identification of high-risk patients, particularly for conditions like atrial fibrillation and heart failure. The device-neutral nature allows for integration with existing monitoring infrastructure. Remember that while the AI provides cardiologist-level accuracy, it serves as an advisory tool and should be used in conjunction with your clinical expertise and patient history.

Idoven's platform is designed for device neutrality and interoperability, supporting data exchange via API and non-API tools (EDF, HL7, DICOM, JSON, XML, PDF). They have established collaborations with major players like AstraZeneca and Google's Fitbit for heart failure detection and remote monitoring, and with Abbott for improving arrhythmia detection in implantable cardiac monitors. The platform seamlessly integrates with current EMR and patient management systems to avoid changes in clinical workflow.

Details

Category Cardiology AI, Clinical Decision Support & Reference
Pricing Contact for pricing
DeploymentCloud-based
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Eu mdr class iia AI-estimated
Integrations
EHR Not specified
Specialties Cardiology, Emergency Medicine, Internal Medicine

What the Web Says

Idoven AI-powered Cardiovascular Care is a health technology company that utilizes artificial intelligence to enhance the speed, consistency, and accuracy of ECG interpretation and prediction, aiming to transform cardiovascular disease diagnosis and care. The platform, powered by its AI algorithm Willem, analyzes large volumes of ECG data from various devices, including wearables, to detect cardiac patterns and identify potential diseases earlier. This technology seeks to address the growing demand for cardiovascular care and the time-consuming nature of manual ECG analysis, ultimately providing faster and more precise diagnoses for patients.

Overall: Positive

Strengths

  • Significantly improves the speed, consistency, and accuracy of ECG interpretation and prediction.
  • Reduces the manual and repetitive tasks of ECG analysis for physicians, freeing up time for patient care.
  • Enhances the ability to identify, triage, and diagnose patients at scale.
  • Offers early detection and precision treatment for cardiovascular diseases.
  • Device-neutral AI software can analyze data from various sources like ECGs, wearables, patches, and implantables.
  • Demonstrated high accuracy in detecting atrial fibrillation from single-lead ECGs.

Limitations

  • Overall evidence on hard clinical outcomes for AI in cardiovascular care remains limited, with short follow-up durations in trials.
  • Some AI models in cardiology have not been independently validated, and others may perform worse for certain demographics.
  • Concerns exist regarding the potential for AI to provide confidently incorrect interpretations, especially with general-purpose AI models.
  • Current evidence base is characterized by trial heterogeneity, considerable risk of bias, and low certainty of evidence.

Based on reviews from: Vertex AI Search, Digital.Health, Insight Partners, Northzone, SoftwareSuggest, Google for Startups, Reddit, Premier Science, PubMed, tctmd.com, YouTube

Last updated: 2026-10-01

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Idoven AI-powered Cardiovascular Care

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Idoven Newsroom
CNN spotlights Idoven and Abbott's Partnership in Finland
CNN featured Idoven's collaboration with Abbott in Finnish hospitals, showcasing how Idoven's AI technology, Willemu2122, is integrated into Abbott's implantable cardiac monitors to transform patient care by prioritizing urgent cases and speeding up decisions.
2024-10
Idoven Newsroom
AstraZeneca and Idoven launch the CONCERTO project to improve early diagnosis of patients with amyloidosis
AstraZeneca and Idoven have partnered to launch the CONCERTO project, aiming to enhance the early diagnosis of patients suffering from amyloidosis.
2025-05
Idoven Newsroom
Idoven featured on the cover of Forward: Unlocking Europe's AI Potential
Idoven was featured on the cover of Google's Forward magazine, which explores how AI can strengthen Europe's competitiveness and society, highlighting Idoven's role in AI-driven healthcare.
2025-09
Idoven Newsroom
Donate Your Heartbeats App: turning everyday signals into life-saving knowledge
Idoven launched the 'Donate Your Heartbeats App', an initiative focused on transforming everyday heart signals into valuable data for life-saving knowledge and research.
2025-09
Idoven Blog
Willem, Idoven's AI Platform, achieves 96.4% accuracy in atrial fibrillation detection from 1-lead ECGs
Idoven's AI platform, Willem, demonstrated a 96.4% accuracy in detecting atrial fibrillation from 1-lead ECGs, showcasing its precision in cardiac rhythm analysis.
2025-02
Cardiovascular Digital Health Journal
Artificial Intelligence Augments Detection Accuracy of Cardiac ICMs
This publication details how artificial intelligence enhances the detection accuracy of cardiac implantable cardiac monitors (ICMs).
2022-XX
Journal of Electrocardiology
AI Cloud Platform Improves Arrhythmia Detection from ICMs to 25 Cardiac Rhythm Patterns through Multi-label Classification
A study published in the Journal of Electrocardiology highlights how an AI cloud platform improves arrhythmia detection from ICMs, expanding the identification to 25 cardiac rhythm patterns using multi-label classification.
2023-XX
Medical AI Tools for Physicians
Idoven AI-powered Cardiovascular Care
Idoven's AI-powered platform revolutionizes ECG interpretation, enabling early detection and precision medicine by detecting 23 unique cardiac patterns.
unknown

Videos

Product demos, reviews, and walkthroughs for Idoven AI-powered Cardiovascular Care.

View all on YouTube

Frequently Asked Questions

Idoven's AI platform is designed to seamlessly integrate with current cardiology workflows by providing cloud-based analysis of ECG data. It offers APIs for integration with various Electronic Health Record (EHR) systems, aiming to streamline data flow and minimize disruption to established clinical practices.
Idoven's AI solution has received CE mark certification as a medical device, indicating compliance with European health, safety, and environmental protection standards. The company also states adherence to GDPR and HIPAA for data privacy and security.
Idoven's AI, specifically its platform called 'W precisely', has demonstrated high accuracy in detecting a range of arrhythmias. Studies have shown its capability to identify up to 80 different arrhythmias with high sensitivity and specificity, often surpassing the diagnostic yield of standard ECG interpretation.
While Idoven's AI shows strong performance, potential limitations could include biases if the training data did not adequately represent diverse patient populations, potentially affecting accuracy in certain demographics or rare cardiac conditions. The company continuously works to expand and diversify its datasets to mitigate such biases.
Idoven typically offers a subscription-based pricing model, which can vary depending on the volume of ECGs analyzed and the specific features required. The cost-benefit considerations for a practice or hospital include improved diagnostic efficiency, reduced need for manual review, and potentially earlier intervention for patients, leading to better outcomes and cost savings in the long run.
Alternatives include other AI-powered ECG analysis platforms, traditional Holter monitoring services with human interpretation, and various cardiac wearable devices. Idoven differentiates itself through its advanced AI algorithms capable of detecting a wide range of arrhythmias, its focus on clinical validation, and its seamless integration capabilities with existing healthcare systems.
Idoven provides comprehensive technical support and training for physicians and their staff. This typically includes onboarding assistance, user manuals, online resources, and dedicated support channels to ensure smooth implementation and effective utilization of their AI platform.

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-07-01 | First Added: 2026-07-01
AI Tool Finder
AI-powered search. Results may not be comprehensive.